What is Ipamorelin used for?

Ipamorelin is a synthetic peptide compound studied in laboratory research settings. Scientific literature has explored its properties in preclinical studies. It is not approved for human consumption.

What purity level does Onward Aminos's Ipamorelin have?

Onward Aminos supplies Ipamorelin at ≥99% purity, verified by third-party HPLC and mass spectrometry analysis. Certificates of Analysis are available upon request.

How is Ipamorelin supplied?

Ipamorelin is supplied as a lyophilized powder in sealed research-grade vials, intended for in vitro and laboratory research use only.

FREE SHIPPING THRESHOLD$250 REMAINING

SYSTEM: ACTIVE·INVENTORY // PEPTIDES·ITEM: IPAMORELIN

MK-IV SPEC Ipamorelin

LAT: 34.0522° NLONG: 118.2437° W

RESEARCH ONLYOA-1025-IPA

Ipamorelin

Name: Ipamorelin
Brand: Onward Aminos
SKU: OA-IPAMORELIN

Selective GH Secretagogue

UNIT COST$31.00

STATUSIN STOCK

SELECT MASS (MG)

QTY

MISSION CRITICAL: For in vitro laboratory research only. Not for human or veterinary use. Not evaluated by the FDA. Must be 21+.

SPECIFICATIONS

CAS No.170851-70-4

Mol. Weight711.87 g/mol

Purity≥99.0% (HPLC)

FormLyophilized Powder

Storage−20°C · Lyophilized

Mol. FormulaC₃₈H₄₉N₉O₅

COMPOUND INTEL

REF #OA-1025-IPA

MECHANISM_DUMP

MOLECULAR PROFILE

Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue. With the molecular formula C₃₈H₄₉N₉O₅ and a molecular weight of 711.9 g/mol (CAS: 170851-70-4), Ipamorelin is derived from the growth hormone-releasing peptide (GHRP) family and exhibits unique selectivity for growth hormone release.

AMINO ACID SEQUENCEAib-His-D-2-Nal-D-Phe-Lys-NH2

Selective GH SecretagogueGHS-R1a (Ghrelin Receptor)Growth Hormone Secretagogue Receptor

MECHANISM OF ACTION

GHS-R1a ReceptorGhrelin receptor agonism

Ipamorelin selectively activates the ghrelin receptor (GHS-R1a) on somatotrophs, stimulating growth hormone release without significantly affecting other pituitary hormones (PMID: 10698741).

Intracellular SignalingIP3/DAG/Ca2+ cascade

Receptor activation triggers phospholipase C-mediated signaling, increasing intracellular calcium and activating protein kinase C (PMID: 11916262).

TECHNICAL DATA

CAS No.: 170851-70-4
Mol. Formula: C₃₈H₄₉N₉O₅
Mol. Weight: 711.87 g/mol
Purity: ≥99.0% (HPLC)
Form: Lyophilized Powder
Storage: −20°C · Lyophilized

PMID REFERENCE LIBRARY

PMID: 10698741

Raun et al. (1998) characterized Ipamorelin's selective binding to GHS-R1a receptors and its effects on growth hormone release in pituitary cell cultures (PMID: 10698741).

Raun K, et al. (1998). Ipamorelin, a selective growth hormone secretagogue. Eur J Endocrinol.PMID: 11916262

Johansen et al. (2002) investigated Ipamorelin's receptor binding kinetics and signaling pathways in CHO cells expressing GHS-R1a (PMID: 11916262).

Johansen PB, et al. (2002). Ipamorelin: pharmacological characterization in vitro. Growth Horm IGF Res.